Exosomal PD-L1 induces osteogenic differentiation and promotes fracture healing by acting as an immunosuppressant
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
A moderate inflammatory response at the early stages of fracture healing is necessary for callus formation. Over-active and continuous inflammation, however, impairs fracture healing and leads to excessive tissue damage. Adequate fracture healing could be promoted through suppression of local over-active immune cells in the fracture site. In the present study, we achieved an enriched concentration of PD-L1 from exosomes (Exos) of a genetically engineered Human Umbilical Vein Endothelial Cell (HUVECs), and demonstrated that exosomes overexpressing PD-L1 specifically bind to PD-1 on the T cell surface, suppressing the activation of T cells. Furthermore, exosomal PD-L1 induced Mesenchymal Stem Cells (MSCs) towards osteogenic differentiation when pre-cultured with T cells. Moreover, embedding of Exos into an injectable hydrogel allowed Exos delivery to the surrounding microenvironment in a time-released manner. Additionally, exosomal PD-L1, embedded in a hydrogel, markedly promoted callus formation and fracture healing in a murine model at the early over-active inflammation phase. Importantly, our results suggested that activation of T cells in the peripheral lymphatic tissues was inhibited after local administration of PD-L1-enriched Exos to the fracture sites, while T cells in distant immune organs such as the spleen were not affected. In summary, this study provides the first example of using PD-L1-enriched Exos for bone fracture repair, and highlights the potential of Hydrogel@Exos systems for bone fracture therapy through immune inhibitory effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Sugiura, D., Maruhashi, T., Okazaki, I.-M., Shimizu, K., Maeda, T. K., Takemoto, T., & Okazaki, T. (2019) · Science · doi:10.1126/science.aav7062 · Cited by 386
Noman, M. Z., Parpal, S., Van Moer, K., Xiao, M., Yu, Y., Arakelian, T., Viklund, J., De Milito, A., Hasmim, M., Andersson, M., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax7881 · Cited by 255
Fan, L., Guan, P., Xiao, C., Wen, H., Wang, Q., Liu, C., Luo, Y., Ma, L., Tan, G., Yu, P., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.005 · Cited by 152
Cited by
Bone Tissue Engineering in the Treatment of Bone Defects
Xue, N., Ding, X., Huang, R., Jiang, R., Huang, H., Pan, X., Min, W., Chen, J., Duan, J.-A., Liu, P., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15070879 · Cited by 441
Xiong, Y., Mi, B.-B., Lin, Z., Hu, Y.-Q., Yu, L., Zha, K.-K., Panayi, A. C., Yu, T., Chen, L., Liu, Z.-P., et al. (2022) · Military Medical Research · doi:10.1186/s40779-022-00426-8 · Cited by 291
Self-citationM2 macrophage-derived exosomes promote diabetic fracture healing by acting as an immunomodulator
Wang, Y., Lin, Q., Zhang, H., Wang, S., Cui, J., Hu, Y., Liu, J., Li, M., Zhang, K., Zhou, F., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.05.018 · Cited by 98
Self-citationEngineering exosomes for bone defect repair
Ma, S., Zhang, Y., Li, S., Li, A., Li, Y., & Pei, D. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1091360 · Cited by 38
Exosomes to exosome-functionalized scaffolds: a novel approach to stimulate bone regeneration
Deng, L., Liu, Y., Wu, Q., Lai, S., Yang, Q., Mu, Y., & Dong, M. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04024-4 · Cited by 32
Metadata
- Authors
- Lin, Z., Xiong, Y., Meng, W., Hu, Y., Chen, L., Chen, L., Xue, H., Panayi, A. C., Zhou, W., Sun, Y., Cao, F., Liu, G., Hu, L., Yan, C., Xie, X., Lin, C., Cai, K., Feng, Q., Mi, B., & Liu, G.
- Venue
- Bioactive Materials
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 13
- Pages
- 300-311
- ISSN
- 2097-1192 (ISSN-L)
- 2452-199X
- OpenAlex
- W3210884827
- Cited by
- 73
- References
- 4
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exosomal PD-L1 induces osteogenic differentiation and promotes fracture healing by acting as an immunosuppressant. https://app.cochat.ai/papers/10.1016/j.bioactmat.2021.10.042
- The paper
- Lin, Z., Xiong, Y., Meng, W., Hu, Y., Chen, L., Chen, L., Xue, H., Panayi, A. C., Zhou, W., Sun, Y., Cao, F., Liu, G., Hu, L., Yan, C., Xie, X., Lin, C., Cai, K., Feng, Q., Mi, B., & Liu, G. (2022). Exosomal PD-L1 induces osteogenic differentiation and promotes fracture healing by acting as an immunosuppressant. Bioactive Materials. https://doi.org/10.1016/j.bioactmat.2021.10.042
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.